PT - JOURNAL ARTICLE AU - Jayadevan, Rajeev AU - Shenoy, Ramesh AU - TS, Anithadevi TI - Survey of symptoms following COVID-19 vaccination in India AID - 10.1101/2021.02.08.21251366 DP - 2021 Jan 01 TA - medRxiv PG - 2021.02.08.21251366 4099 - http://medrxiv.org/content/early/2021/02/12/2021.02.08.21251366.short 4100 - http://medrxiv.org/content/early/2021/02/12/2021.02.08.21251366.full AB - Background COVID-19 vaccines have been rolled out recently in several parts of the world. Although the protective efficacy is frequently discussed, little is known about the real-world post-vaccination experience outside of clinical trial conditions. Knowledge about what to expect after vaccination will help educate the public, dispel misinformation and reduce vaccine hesitancy.AimTo assess the immediate response to the first dose of COVID-19 vaccine.To study the spectrum of post-vaccination symptom profile for individual vaccines.Methods A cross-sectional online survey was done which included questions pertaining to the immediate post vaccination experience in India.Results A total of 5396 people responded to the survey over a one-week period from 29 January to 4 February. Overall, 65.9 % of respondents reported at least one post-vaccination symptom. Tiredness (45%), myalgia (44%), fever (34%), headache (28%), local pain at injection site (27%), joint pain (12%), nausea (8%) and diarrhea (3%) were the most prevalent symptoms. The chance of having symptoms decreased with advancing age. The frequency of symptoms was 81% (3rd decade or 20-29 years), 80% (4th decade or 30-39 years), 68% (5th decade), 58% (6th decade), 45% (7th decade), 34% (8th decade) and 7% (9th decade, 80-90 years). Post-vaccination symptoms were more likely to be reported by women (74.7%) compared to men (58.6%) (p < 0.001). Among those who reported symptoms, 79% noticed them within the first 12 hours. 472 out of 5396 (8.7%) reported past history of COVID-19. Their symptom profile was not different to those who did not have a past history.Conclusions Two-thirds of healthcare professionals who completed the survey reported mild and short-lived post-vaccination symptoms. Tiredness, myalgia and fever were most commonly reported. These symptoms were consistent with an immune response commonly associated with vaccines, and correlated with the findings from previously published phase 2/3 trials. In 90% cases, the symptoms were either milder than expected or meeting the expectation of the vaccine recipient. No serious events were reported. Symptoms were more common among younger individuals. There was no difference in symptoms among those who had a past history of COVID-19.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding involvedAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below: The study had been approved by Ethics committee of Indian Medical Association, Cochin Branch, Kerala, India. The ethics committee consists of: 1. Dr TV Ravi, President, Indian Medical Association Cochin Branch 2. Dr VD Pradeepkumar, Past Vice President, Indian Medical Association Kerala State Affiliations of Dr TV Ravi and Dr VD Pradeepkumar: Ernakulam Medical Centre, National Highway Bypass, NH 66, Palarivattom, Kochi, Kerala 682028 All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData will be furnished upon request, including the raw data excel file of the 5396 respondents.